Records containing: Idiopathic Pulmonary Fibrosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-11-14Pilot Study Phase III to Evaluate the Efficacy and Safety of Trimethoprim-sulfamethoxazole in the Treatment of Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2017-11-09Does 4 Metre Gait Speed (4MGS) Predict Mortality and Non-elective Hospitalisation in Patients With Idiopathic Pulmonary Fibrosis (IPF)?
-
CLINICAL_TRIALS study record update · 2017-11-09Responsiveness of the 4 Metre Gait Speed in Patients With Idiopathic Pulmonary Fibrosis and Determination of the Minimum Important Difference
-
CLINICAL_TRIALS study record update · 2017-10-30A Single Arm, Multicenter, Open-label, Phase 1b Study to Assess the Safety and Tolerability of Oral Vismodegib in Combination With Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2017-07-12Prevalence and Impact on Quality of Life of Airway Disease in Patients With Idiopathic Pulmonary Fibrosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-06-14Phase II Study of Inhaled CO for the Treatment of Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2017-05-31Clinical, Radiological Characteristics and Health Related Quality of Life in Idiopathic Pulmonary Fibrosis Patients
-
CLINICAL_TRIALS study record update · 2017-05-15A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2017-05-15Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide
-
CLINICAL_TRIALS study record update · 2017-05-08Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2017-05-01A FTIH Study With GSK3008348 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2017-04-28Prospective Evaluation of Patients With Idiopathic Pulmonary Fibrosis Through an IPF Registry
-
CLINICAL_TRIALS study record update · 2017-04-21Post-Authorisation Safety Study of Esbriet® (Pirfenidone): A Prospective Observational Registry to Evaluate Long-Term Safety in a Real-World Setting
-
CLINICAL_TRIALS study record update · 2017-04-19The Registry of Controls for Respiratory Diseases
-
CLINICAL_TRIALS study record update · 2017-04-13A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2017-04-07Safety and Diagnostic Performance of 68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2017-04-04A Phase 2, Long-Term Safety Study of GS-6624 in Adult Subjects With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2017-03-29Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2017-03-29An Open-Label Extension Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2017-03-17A Study to Assess the Tolerability of a Single Dose of AF-219, a P2X3 Receptor Antagonist, in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2017-02-28Clinical Course of Treatment With ESBRIET in Patients With Mild to Moderate IPF
-
CLINICAL_TRIALS study record update · 2017-02-24The Inflammatory and Antioxidant Status in Pulmonary Sarcoidosis, Idiopathic Pulmonary Fibrosis and COPD: a Potential Role for Antioxidants
-
CLINICAL_TRIALS study record update · 2017-02-23A Phase 2, Multicenter, Double-Blind Within Cohort, Dose-escalation Study to Evaluate the Safety and Tolerability of Multiple Doses of CAT-354 (Tralokinumab) in Japanese Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2016-12-23Observational Study of the Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2016-11-02ClinicalTrials.gov study NCT02168530